Glucagon-like peptide-1(7–36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns
The DOI matches its Crossref record.
Abstract
The acute effects of different macronutrients on the secretion of glucagon-like peptide-1(7–36)amide (GLP-1(7–36)amide) and glucose-dependent insulinotropic polypeptide (GIP) were compared in healthy human subjects. Circulating levels of the two hormones were measured over a 24-h period during which subjects consumed a mixed diet. In the first study, eight subjects consumed three equicaloric (375 kcal) test meals of carbohydrate, fat and protein. Small increases in plasma GLP-1(7–36) amide were found after all meals. Levels reached a maximum 30 min after the carbohydrate and 150 min after the fat load. Ingestion of both carbohydrate and fat induced substantial rises in GIP secretion, but the protein meal had no effect. In a second study, eight subjects consumed 75 g glucose or the equivalent portion of complex carbohydrate as boiled brown rice or barley. Plasma GIP, insulin and glucose levels increased after all three meals, the largest increase being observed following glucose and the smallest following the barley meal. Plasma GLP-1(7–36)amide levels rose only following the glucose meal. In the 24-h study, plasma GLP-1(7–36)amide and GIP concentrations were increased following every meal and remained elevated throughout the day, only falling to fasting levels at night. The increases in circulating GLP-1(7–36)amide and GIP levels following carbohydrate or a mixed meal are consistent with their role as incretins. The more sustained rises observed in the daytime during the 24-h study are consistent with an anabolic role in lipid metabolism. Journal of Endocrinology (1993) 138, 159–166
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The gut-derived hormones GLP-1 and GIP, which are secreted from enteroendocrine L-cells66 and K-cells,67 respectively, upon glucose,66, 68 fructose,69 amino acid70 and free fatty acid (FFA)71, 72 ingestion, also potentiate insulin release through the so-called incretin effect.”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [68]
Citations
Cites
Still being checked.
Cited by
Items 201–300 of 696
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
Hjørne, A. P., Modvig, I. M., & Holst, J. J. (2022) · Metabolites · doi:10.3390/metabo12050420 · Cited by 71
Baggio, L. (2000) · Endocrinology · doi:10.1210/en.141.10.3703 · Cited by 79
Thondam, S. K., Cuthbertson, D. J., & Wilding, J. P. H. (2020) · Peptides · doi:10.1016/j.peptides.2019.170208 · Cited by 77
Damholt, A. B. (1998) · Endocrinology · doi:10.1210/en.139.4.2085 · Cited by 72
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
Monti, G., Gomes Moreira, D., Richner, M., Mutsaers, H. A. M., Ferreira, N., & Jan, A. (2022) · Cells · doi:10.3390/cells11132023 · Cited by 68
Sonne, D. P., Hansen, M., & Knop, F. K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0154 · Cited by 75
Glucagonlike Peptide-1 (GLP-1) Participation in Ileal Brake Induced by Intraluminal Peptones in Rat
Giralt, M., & Vergara, P. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026654417697 · Cited by 82
Pullulan Is a Slowly Digested Carbohydrate in Humans
Wolf, B. W., Garleb, K. A., Choe, Y. S., Humphrey, P. M., & Maki, K. C. (2003) · Journal of Nutrition · doi:10.1093/jn/133.4.1051 · Cited by 81
Damcı, T., Yalın, S., Balcı, H., Oşar, Z., Korugan, Ü., Özyazar, M., & ILKOVA, H. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1077 · Cited by 78
Glucose transporters are expressed in taste receptor cells
Merigo, F., Benati, D., Cristofoletti, M., Osculati, F., & Sbarbati, A. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01385.x · Cited by 75
Energy intake and obesity: Ingestive frequency outweighs portion size
Mattes, R. D. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.11.012 · Cited by 83
Holst, J. J., Albrechtsen, N. J. W., Rosenkilde, M. M., & Deacon, C. F. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180013 · Cited by 54
Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1
Reimann, F., Ward, P. S., & Gribble, F. M. (2006) · Diabetes · doi:10.2337/db06-s010 · Cited by 68
Intestinal GLP-1 and satiation: from man to rodents and back
Steinert, R. E., Beglinger, C., & Langhans, W. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.172 · Cited by 78
Incretin Mimetics as Emerging Treatments for Type 2 Diabetes
Joy, S. V., Rodgers, P. T., & Scates, A. C. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e245 · Cited by 71
Oral Delivery of Glucagon Like Peptide-1 by a Recombinant Lactococcus lactis
Agarwal, P., Khatri, P., Billack, B., Low, W., & Shao, J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1430-3 · Cited by 74
Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance
Pujadas, G., & Drucker, D. J. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1078 · Cited by 65
Nutrients related to GLP1 secretory responses
Mansour, A., Hosseini, S., Larijani, B. A., Pajouhi, M., & Mohajeri‐Tehrani, M. R. (2013) · Nutrition · doi:10.1016/j.nut.2012.11.015 · Cited by 75
Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake
Caron, J., Domenger, D., Dhulster, P., Ravallec, R., & Cudennec, B. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00085 · Cited by 61
Modvig, I. M., Kuhre, R. E., & Holst, J. J. (2019) · Physiological Reports · doi:10.14814/phy2.14056 · Cited by 64
Robertson, M. D., Jackson, K. G., Fielding, B. A., Morgan, L., Williams, C. M., & Frayn, K. N. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.232 · Cited by 73
Self-citationWettergren, A., Wøjdemann, M., & Holst, J. J. (1998) · Peptides · doi:10.1016/s0196-9781(98)00020-5 · Cited by 67
Circadian rhythms and pancreas physiology: A review
Chan, K., Wong, F. S., & Pearson, J. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.920261 · Cited by 69
Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
Torekov, S. S., Madsbad, S., & Holst, J. J. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00860.x · Cited by 65
Tunnicliffe, J. M., Eller, L. K., Reimer, R. A., Hittel, D. S., & Shearer, J. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-072 · Cited by 63
Shimotoyodome, A., Suzuki, J. S., Fukuoka, D., Tokimitsu, I., & Hase, T. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00468.2009 · Cited by 71
Smith, C. E., Mollard, R. C., Luhovyy, B. L., & Anderson, G. H. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000700 · Cited by 75
Peyot, M.-L., Gray, J. P., Lamontagne, J., Smith, P. J. S., Holz, G. G., Madiraju, S. R. M., Prentki, M., & Heart, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006221 · Cited by 64
Wettergren, A., Maina, P., Boesby, S., & Holst, J. J. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709025098 · Cited by 65
Modvig, I. M., Kuhre, R. E., Jepsen, S. L., Xu, S. F. S., Engelstoft, M. S., Egerod, K. L., Schwartz, T. W., Ørskov, C., Rosenkilde, M. M., & Holst, J. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00026.2021 · Cited by 58
Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
Punjabi, M., Arnold, M., Geary, N., Langhans, W., & Pacheco‐López, G. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.02.038 · Cited by 75
Huber, H., Schieren, A., Holst, J. J., & Simon, M.-C. (2024) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.01.007 · Cited by 62
“…and fat have been described to be strong GLP-1 secretagogues after they have been orally ingested or directly administered into the intestine [32,124 – 126]; with carbohydrate and proteins eliciting earlier peaks in GLP-1 secretion (30 – 60 min postprandially) than lipids ( > 120 min…”
BackgroundNagamine, R., Ueno, S., Tsubata, M., Yamaguchi, K., Takagaki, K., Hira, T., Hara, H., & Tsuda, T. (2014) · Food & Function · doi:10.1039/c4fo00032c · Cited by 67
Steinert, R. E., Feinle‐Bisset, C., Geary, N., & Beglinger, C. (2013) · Journal of Animal Science · doi:10.2527/jas.2012-6022 · Cited by 67
Palladino, A. A., Sayed, S., Levitt Katz, L. E., Gallagher, P. R., & De León, D. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1263 · Cited by 61
GLP-1 and type 2 diabetes: physiology and new clinical advances
Combettes, M. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.003 · Cited by 69
The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes
Adamska, E., Ostrowska, L., Górska, M., & Krętowski, A. (2014) · Gastroenterology Review · doi:10.5114/pg.2014.42498 · Cited by 60
Li, J., An, R., Zhang, Y., Li, X., & Wang, S. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037440 · Cited by 66
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients
Sonne, D. P., Hare, K. J., Martens, P. C., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00435.2012 · Cited by 64
Punjabi, M., Arnold, M., Rüttimann, E., Graber, M., Geary, N., Pacheco-López, G., & Langhans, W. (2014) · Endocrinology · doi:10.1210/en.2013-1447 · Cited by 59
Possible role of PEPT1 in gastrointestinal hormone secretion
Matsumura, K., Miki, T., Jhomori, T., Gonoi, T., & Seino, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.259 · Cited by 64
The role of the Wnt signaling pathway in incretin hormone production and function
Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 63
Dietary Effects on Incretin Hormone Secretion
Wu, T., Rayner, C. K., Jones, K. L., & Horowitz, M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00003-5 · Cited by 62
Mechanisms and effects of “fat taste” in humans
Tucker, R. M., Mattes, R. D., & Running, C. A. (2014) · BioFactors · doi:10.1002/biof.1162 · Cited by 61
Modulating GPR40: therapeutic promise and potential in diabetes
Poitout, V., & Lin, D. C.-H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.09.003 · Cited by 62
The entero-insular axis: implications for human metabolism
Ranganath, L. R. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.008 · Cited by 71
Intestinal hormones and growth factors: Effects on the small intestine
Drozdowski, L. A., & Thomson, A. B. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.385 · Cited by 65
Wölnerhanssen, B. K., Moran, A. W., Burdyga, G., Meyer‐Gerspach, A. C., Peterli, R., Manz, M., Thumshirn, M., Daly, K., Beglinger, C., & Shirazi‐Beechey, S. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08487-9 · Cited by 62
The ageing entero-insular axis
Ranganath, L. R., Sedgwick, I., Morgan, L. D., Wright, J., & Marks, V. (1998) · Diabetologia · doi:10.1007/s001250051070 · Cited by 60
Self-citationKohanmoo, A., Faghih, S., & Akhlaghi, M. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113123 · Cited by 56
Circadian Regulation of Metabolism: Commitment to Health and Diseases
Sato, T., & Sato, S. (2023) · Endocrinology · doi:10.1210/endocr/bqad086 · Cited by 63
Lu, W. J., Yang, Q., Sun, W., Woods, S. C., D'Alessio, D., & Tso, P. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00146.2007 · Cited by 55
McKay, N. J., Galante, D. L., & Daniels, D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3267-14.2014 · Cited by 55
“The presence of nutrients in the gut stimulates release of intestinal GLP-1 into circulation (Elliott et al., 1993; Orskov et al., 1996), whereas meal intake increases cFos in hindbrain GLP-1positive cells (Kreisler et al.”
BackgroundSakamoto, E., Seino, Y., Fukami, A., Mizutani, N., Tsunekawa, S., Ishikawa, K., Ogata, H., Uenishi, E., Kamiya, H., Hamada, Y., et al. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00208.x · Cited by 51
GIP analogues and the treatment of obesity-diabetes
Bailey, C. J. (2019) · Peptides · doi:10.1016/j.peptides.2019.170202 · Cited by 59
Gut hormones as pharmaceuticals
Holst, J. J. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00185-3 · Cited by 65
Shannon, M., Green, B., Willars, G., Wilson, J., Matthews, N., Lamb, J., Gillespie, A., & Connolly, L. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.015 · Cited by 51
Nie, Y., Ma, R. C., Chan, J. C. N., Xu, H., & Xu, G. (2012) · The FASEB Journal · doi:10.1096/fj.11-196782 · Cited by 53
Leckström, A., Kim, E. R., Wong, D., & Mizuno, T. M. (2008) · Diabetes · doi:10.2337/db08-0260 · Cited by 53
GIP or not GIP? That is the question
Kieffer, T. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00031-2 · Cited by 56
Incretin Hormone Secretion Over the Day
Åhrén, B., Carr, R. D., & Deacon, C. F. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00007-2 · Cited by 54
Muñoz, J. S. G., Jiménez‐Rodríguez, D., & Morante, J. J. H. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0375-7 · Cited by 56
The regulation of function, growth and survival of GLP-1-producing L-cells
Kuhre, R. E., Holst, J. J., & Krizhanovskii, C. (2015) · Clinical Science · doi:10.1042/cs20150154 · Cited by 54
Appetite control after weight loss: what is the role of bloodborne peptides?
Doucet, É., & Cameron, J. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-019 · Cited by 51
Aziz, A. A., & Anderson, G. H. (2003) · Journal of Nutrition · doi:10.1093/jn/133.7.2326 · Cited by 57
Gosby, A. K., Lau, N. S., Tam, C. S., Iglesias, M. A., Morrison, C. D., Caterson, I. D., Brand-Miller, J., Conigrave, A. D., Raubenheimer, D., & Simpson, S. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161003 · Cited by 51
Iwasaki, M., Minami, K., Shibasaki, T., Miki, T., Miyazaki, J., & Seino, S. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00026.x · Cited by 57
Physiological mechanisms mediating aspartame-induced satiety
Hall, W. L., Millward, D. J., Rogers, P. J., & Morgan, L. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00034-9 · Cited by 51
Self-citationMessenger, B., Clifford, M., & Morgan, L. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770407 · Cited by 49
Self-citationMoritoh, Y., Takeuchi, K., & Hazama, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01156.x · Cited by 52
Jácome-Sosa, M., Parks, E. J., Bruno, R. S., Tasali, E., Lewis, G. F., Schneeman, B. O., & Rains, T. M. (2016) · Advances in Nutrition · doi:10.3945/an.115.010397 · Cited by 51
No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man
Long, S. J., Sutton, J. A., Amaee, W. B., Giouvanoudi, A., Spyrou, N. M., Rogers, P. J., & Morgan, L. M. (1999) · British Journal of Nutrition · doi:10.1017/s0007114599000513 · Cited by 49
Self-citationA role for the gut-to-brain GLP-1-dependent axis in the control of metabolism
Burcelin, R., Sérino, M., & Cabou, C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.003 · Cited by 52
Retlich, S., Duval, V., Ring, A., Staab, A., Hüttner, S., Jungnik, A., Jaehde, U., Dugi, K. A., & Graefe‐Mody, U. (2010) · Clinical Pharmacokinetics · doi:10.2165/11536620-000000000-00000 · Cited by 53
Işbil-Büyükcoşkun, N., & Süyen, G. G. (2003) · Regulatory Peptides · doi:10.1016/j.regpep.2003.10.025 · Cited by 54
Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats
Gülpinar, M. A., Bozkurt, A., Coşkun, T., Ulusoy, N. B., & Yeǧen, B. Ç. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g924 · Cited by 48
RANGANATH, L., NORRIS, F., MORGAN, L., WRIGHT, J., & MARKS, V. (1999) · Clinical Science · doi:10.1042/cs0960335 · Cited by 47
Self-citationIs there a role for glucagon‐like peptide‐1 receptor agonists in the treatment of male infertility?
Cannarella, R., Calogero, A. E., Condorelli, R. A., Greco, E. A., Aversa, A., & Vignera, S. L. (2021) · Andrology · doi:10.1111/andr.13015 · Cited by 60
Incretin-based therapies: mimetics versus protease inhibitors
Brubaker, P. L. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.06.005 · Cited by 48
Recent Advances in Antidiabetic Drug Therapies Targeting the Enteroinsular Axis
Flatt, P., Bailey, C., & Green, B. (2009) · Current Drug Metabolism · doi:10.2174/138920009787522124 · Cited by 46
Gastro-intestinal hormones GIP and GLP-1
Kieffer, T. J. (2004) · Annales d Endocrinologie · doi:10.1016/s0003-4266(04)95625-9 · Cited by 49
Dühlmeier, R., Deegen, E., Fuhrmann, H., Widdel, A., & Sallmann, H. ‐. (2001) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(01)00295-1 · Cited by 46
Khattab, M., Abi-Rashed, C., Ghattas, H., Hlais, S., & Obeid, O. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0101-5 · Cited by 47
Pancreatic .BETA.-cell signaling: toward better understanding of diabetes and its treatment
SEINO, S., SHIBASAKI, T., & MINAMI, K. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.563 · Cited by 42
Alsalim, W., Tura, A., Pacini, G., Omar, B., Bizzotto, R., Mari, A., & Åhrén, B. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12570 · Cited by 223
A Randomised Crossover Trial: The Effect of Inulin on Glucose Homeostasis in Subtypes of Prediabetes
Guess, N. D., Dornhorst, A., Oliver, N., & Frost, G. S. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000441626 · Cited by 45
Novel insight into the distribution of L-cells in the rat intestinal tract.
Hansen, C. F., Vrang, N., Sangild, P. T., & Jelsing, J. (2013) · Europe PMC (PubMed Central) · Cited by 61
Ability of GLP-1 to decrease food intake is dependent on nutritional status
Ronveaux, C. C., de Lartigue, G., & Raybould, H. E. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.06.015 · Cited by 41
Pathophysiology of diabetes mellitus type 2: beyond the duo "insulin resistance-secretion deficit".
Boada, C. A. C., & Martínez-Moreno, J. M. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6717 · Cited by 79
Chueire, V. B., & Muscelli, E. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000313 · Cited by 50
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes
Parsons, G. B., Souza, D. W., Wu, H., Yu, D., Wadsworth, S. G., Gregory, R. J., & Armentano, D. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302842 · Cited by 45
Van Citters, G. W., Kabir, M., Kim, S. P., Mittelman, S. D., Dea, M. K., Brubaker, P. L., & Bergman, R. N. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020002 · Cited by 43
Saltiel, M., Kuhre, R., Christiansen, C., Eliasen, R., Conde-Frieboes, K., Rosenkilde, M., & Holst, J. (2017) · Nutrients · doi:10.3390/nu9040418 · Cited by 43
Nutrient sensing of gut luminal environment
Moran, A. W., Daly, K., Al-Rammahi, M. A., & Shirazi‐Beechey, S. P. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120007120 · Cited by 45
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
Stemmer, K., Finan, B., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.008 · Cited by 43
Decreased Basal Levels of Glucagon-Like Peptide-1 after Weight Loss in Obese Subjects
de Luis, D. A., Gonzalez Sagrado, M., Conde, R., Aller, R., & Izaola, O. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000103273 · Cited by 41
Harnessing the gut to treat diabetes
Fujita, Y., Cheung, A. T., & Kieffer, T. J. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00080.x · Cited by 47
Dynamic Uni- and Multicellular Patterns Encode Biphasic Activity in Pancreatic Islets
Jaffredo, M., Bertin, É., Pirog, A., Puginier, E., Gaitan, J., Ouchérif, S., Lebreton, F., Bosco, D., Catargi, B., Cattaert, D., et al. (2021) · Diabetes · doi:10.2337/db20-0214 · Cited by 45
Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
Opinto, G., Natalicchio, A., & Marchetti, P. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.812664 · Cited by 51
Protein- and Calcium-Mediated GLP-1 Secretion: A Narrative Review
Watkins, J. D., Koumanov, F., & Gonzalez, J. T. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab078 · Cited by 40
Metadata
- Authors
- Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J., & Marks, V.
- Affiliations
- University of Surrey (GB)
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1993-07-01
- Volume
- 138
- Issue
- 1
- Pages
- 159-166
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2027593203
- Cited by
- 695
- References
- 0
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 15 · 2023: 11 · 2022: 20 · 2021: 28 · 2020: 16 · 2019: 26 · 2018: 28 · 2017: 23 · 2016: 19 · 2015: 36 · 2014: 35 · 2013: 39 · 2012: 32
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Funders
- Ministry of Agriculture, Forestry and Fisheries
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon-like peptide-1(7-36)amide, glucose-dependent insulinotropic polypeptide, incretins, postprandial hormone secretion, carbohydrate intake, dietary fat, dietary protein, glucose, barley, brown rice, insulin, lipid metabolism
- MeSH terms
- Adult, Blood Glucose, Circadian Rhythm, Dietary Carbohydrates, Dietary Fats, Dietary Proteins, Eating, Glucagon-Like Peptides, Gastric Inhibitory Polypeptide, Glucagon, Glucose, Humans, Insulin, Nutritional Physiological Phenomena, Peptide Fragments, Radioimmunoassay, Time Factors, Lipid Metabolism, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.